New Zealand -
English -
Medsafe (Medicines Safety Authority)
simponi
janssen-cilag (new zealand) ltd - golimumab 50mg; - solution for injection - 50 mg - active: golimumab 50mg excipient: histidine polysorbate 80 sorbitol water for injection - rheumatoid arthritis: simponi, in combination with mtx, is indicated for: · the treatment of active rheumatoid arthritis in adult patients when the response to dmard therapy has been inadequate. · the treatment of active rheumatoid arthritis in adult patients not previously treated with mtx. simponi has also been shown to reduce the rate of progression of joint damage as measured by x-ray, improve physical function and health related quality of life. simponi can be used in patients previously treated with one or more tnf inhibitor(s).
Singapore -
English -
HSA (Health Sciences Authority)
simponi solution for injection in pre-filled pen 45mg0.45ml
johnson & johnson international (singapore) pte ltd - golimumab - injection, solution - golimumab 45mg/0.45ml
Singapore -
English -
HSA (Health Sciences Authority)
simponi® i.v. concentrate for solution for infusion 12.5mg1 ml
johnson & johnson international (singapore) pte ltd - golimumab - infusion, solution concentrate - golimumab 12.5mg/1 ml in 4 ml vial
Canada -
English -
Health Canada
simponi solution
janssen inc - golimumab - solution - 50mg - golimumab 50mg - disease-modifying antirheumatic agents
Canada -
English -
Health Canada
simponi solution
janssen inc - golimumab - solution - 50mg - golimumab 50mg - disease-modifying antirheumatic agents
Canada -
English -
Health Canada
simponi solution
janssen inc - golimumab - solution - 100mg - golimumab 100mg - disease-modifying antirheumatic agents
Canada -
English -
Health Canada
simponi solution
janssen inc - golimumab - solution - 100mg - golimumab 100mg - disease-modifying antirheumatic agents
Canada -
English -
Health Canada
simponi i.v. solution
janssen inc - golimumab - solution - 50mg - golimumab 50mg - disease-modifying antirheumatic agents
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
simponi 50mg0.5ml solution for injection pre-filled syringes
merck sharp & dohme ltd - golimumab - solution for injection - 100mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
simponi 50mg0.5ml solution for injection pre-filled pen
merck sharp & dohme ltd - golimumab - solution for injection - 100mg/1ml